Show results for
Refine by
Industries served
- Medical / Health Care
- Monitoring and Testing
- Chemical & Pharmaceuticals
- Water and Wastewater
- Food and Beverage
- Waste and Recycling
- Agriculture
- Health and Safety
- Manufacturing, Other
- Energy
- Construction & Construction Materials
- Defense
- Retail
- Commercial
- Real Estate
- Maritime/Shipbuild/Water Transport
- Oil, Gas & Refineries
- Environmental
- Air and Climate
- University / Academia / Research
- Government
- Publishing / Media / Marketing
Neurodegenerative Suppliers Serving Maldives
54 companies found
Premium
based inMontigny-le-Bretonneux, FRANCE
Bertin Technologies is a French industrialist in scientific instrumentation that designs and manufactures, in France and in Europe, measurement, observation & detection systems and instruments for critical applications. Every day, Bertin ...
Bertin Bioreagent offers primary and secondary antibodies for laboratories. As essential tools, they are particularly versatile when properly ...
based inSeocho-gu, SOUTH KOREA
We are on a mission to “View the Invisible, Know the Unknown”, and have goals to suggest optimal treatments to medical practitioners and to find biomarkers that help to develop the treatment. VUNO Inc. was founded by three insightful leaders in ...
VUNO Med-DeepBrain serves as a supporting tool for diagnosis of neurodegenerative diseases to execute brain parcellation in brain MRI and provide quantitative data on brain ...
based inDerio, SPAIN
Innoprot is a company specializing in the development and provision of high-quality cell lines and assays for use in research and drug discovery. They offer a wide array of G protein-coupled receptor (GPCR) cell lines, which are essential for ...
based inGangnam-gu, SOUTH KOREA
MitoImmune Therapeutics Inc. is a drug discovery and development biotech company that harnesses the power of mitochondria and its proprietary technology targeting mitochondria as the source for developing new potential breakthrough therapeutics. Our ...
The blood-brain barrier (BBB) penetrating technology is essential to develop drugs for neurodegenerative diseases, such as Alzheimer’s, Parkinson’s, ALS, and Huntington’s disease, which have high unmet medical ...
based inWarszawa, POLAND
NeuroDevice Group is a clinical stage company working on the development and implementation of projects from various fields of neuroscience. We develop technology enabling innovative therapy for patients suffering from nervous system disorders using ...
based inYokohama, JAPAN
We provide a unique combination of services and products to power your translational research. With scientists and laboratories on three continents, REPROCELL has the scientific and clinical expertise to better translate your discoveries into ...
based inDallas, TEXAS (USA)
Vaxxinity is a U.S.-based global biotechnology company pioneering a new class of medicines to democratize health. Headquartered in Dallas, TX, with operations in the United States, Latin America, Europe and Asia, the company’s proprietary technology ...
We are developing an anti-tau product candidate that has the potential to address multiple neurodegenerative conditions, including AD, by targeting abnormal tau proteins alone and in potential combination with other pathological ...
based inBentley DC, AUSTRALIA
Ozgene is one of the leading companies providing genetically modified mice for researchers around the world. We offer a full spectrum of pre-clinical capabilities from the development of mouse models through to breeding, characterisation and ...
based in, MASSACHUSETTS (USA)
Thermo Scientific instruments, equipment, software, services and consumables empower scientists to solve for complex analytical challenges in pharmaceutical, biotechnology, academic, government, environmental and industrial research, as well as the ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
Deferoxamine mesylate also shows anti-proliferative activity, can induce apoptosis and autophagy in cancer cells. Deferoxamine mesylate can be used in studies of diabetes, neurodegenerative diseases as well as anti-cancer and ...
based inMonmouth Junction, NEW JERSEY (USA)
DiamiR is a privately held molecular diagnostics company focused on developing minimally invasive tests for detection and monitoring of pathology based on quantitative analysis of organ-enriched microRNA signatures in plasma for screening, patient ...
based inMesa, ARIZONA (USA)
BMSEED is a manufacturer of research equipment that replicates in vitro, stretch-induced neurotrauma (e.g. TBI, SCI) for high-content screening of treatment therapies and injury mechanisms in academic research and pharmaceutical settings. The ...
based inHuningue, FRANCE
FIRALIS is a biotechnology company located in the very heart of BioValley, on the true triple border of FR-DE-CH, only a few minutes walking distance to Basel, the pharmaceutical capital of Europe. Firalis creates novel values via biomarker ...
NEUROLINCS : A non-invasive in-vitro diagnostic test measuring 7494 brain-enriched long non-coding RNAs (lncRNAs) that are specific to neurodegenerative ...
based inNes-Ziona, ISRAEL
Kadimastem is a bio-pharmaceutical company that develops industrial regenerative medicine therapies based on differentiated cells derived from Human Embryonic Stem Cells (hESCs) to treat neuro-degenerative diseases such as ALS and Diabetes. ...
Clinical grade human astrocytes (the nervous system supporting cells) for the treatment of ALS and other neurodegenerative diseases. Received approval by the Israeli Ministry of Health to commence our phase I/IIa clinical trial in ...
based inDwarka, INDIA
Everflow Global. We are a leading company engaged in water & air treatment using the bioremediation Process. We offer you the best technology in industrial wastewater treatment. Our cleantech solutions are focused on Carbon negative and ...
based in, GERMANY
betaSENSE is transforming the landscape of protein diagnostics by focusing on the early detection of neurodegenerative diseases, such as Alzheimer's and Parkinson's. Emerging from pioneering research at Ruhr University Bochum, led by Prof. Dr. Klaus ...
betaSENSE has developed a cutting-edge platform technology leveraging the principles of infrared spectroscopy to advance diagnostics in neurodegenerative disorders. The technology, known as betaSENSE, utilizes differential ...
based inLondon, UNITED KINGDOM
ReGen (Therapeutics Plc) was formed in February 1998 to develop Colostrinin™, a proline-rich polypeptide complex derived from mammalian colostrum. Colostrinin™ is promoted as having utility as a support for healthy brain ageing and cognition. ...
ReGen Therapeutics was formed in February 1998 to develop Colostrinin™, a proline-rich polypeptide complex derived from mammalian colostrum. The complex and the peptides within it are viewed as having potential utility in ...
based inEncinitas, CALIFORNIA (USA)
Neurodigitech (NDT) is dedicated to 1) Neurohistological and neuropathological services of the central nervous system (CNS), 2) Neural staining kits, 3) High-throughput digital microscopic imaging and stereology-based quantitative morphology, and 4) ...
The NDT teams in specialized in both non-GLP and GLP compliant pre-clinical assessments of CNS disease therapeutics using a variety of biomarkers, including histology, immunohistochemical and histochemical methods. In particular, NDT is dedicated to ...
based inGloucestershire, UNITED KINGDOM
Renishaw is a global, high precision metrology and healthcare technology group. We design, develop and deliver solutions and systems that provide unparalleled precision, control and reliability. We are also a world leader in the field of additive ...
based inPortland, OREGON (USA)
APDM was founded with the objective of creating novel technologies to enable the scientific community to conduct quality research in movement science, accelerate clinical trials by introducing a new generation of biomarkers and validated endpoints, ...
